Search

Amidst this larger debate about drug prices and pharmaceutical innovation, there is a growing consensus of a need for reform in the industry and how it is regulated. The substance of the necessary reforms remains subject to great debate, however, and the policies chosen by Congress are likely to have significant consequences for the public….

Presentation Alison Galvani’s paper: Long-standing influenza vaccination policy is in accord with individual self-interest but not with the utilitarian optimum

Presentation Download Adriana Lleras-Muney’s paper: Understanding Differences in Health Behaviors by Education

On the occasion of publication of a new book on physician conscience clauses written by Holly Fernandez Lynch, this panel examined the legal and ethical aspects of the current debates surrounding physicians and health care practitioner’s rights to refuse to perform legally permissible medical procedures on the grounds of moral objections. The author of Conflicts…

Presentation Theodore Marmor’s paper : Comparative Perspectives and Policy Learning in the World of Health Care

Presentation Jeff McMahan’s paper: Radical Cognitive Limitation

Presentation F. M. Scherer’s paper: Markets and Uncertainty in Pharmaceutical Development

Presentation Anup Malani’s paper: Clinical Trials, the Market for Observations and the Cost of Medical R&D

Presentation Henry Grabowski’s paper: Priority Review Vouchers to Encourage Innovation for Neglected Diseases

With the advance of medical technologies and the increasing power over life and death that they afford, discussions of “human dignity” have begun to take a more central role in bioethics. How should we view this dignity discourse? Is “human dignity” a useful concept that leads to determinate answers on issues like stem cell research…